한글목차

세계의 홈헬스케어 시장 규모는 2023년 2,500억 달러에서 2028년에는 3,830억 달러에 달할 것으로 예측되며, 예측 기간 중 CAGR은 8.9%에 달할 것으로 보이고 있습니다.

이 시장 성장의 주요 요인은 홈헬스케어 상품과 서비스에서 신기술의 도입입니다.

검사·스크리닝·모니터링용 제품, 치료용 제품, 모바일 케어 품목이 재택 헬스케어 시장 부문을 구성하고 있으며, 2022년 재택 헬스케어 시장에서 가장 높은 성장률을 기록한 것은 치료용품 부문입니다. 만성질환 증가가 시장 확대의 주요 원인입니다.

숙련된 간호, 재활 치료, 호스피스 및 완화 치료, 미숙련 치료, 호흡 치료, 수액 치료, 산전 관리 서비스는 재택치료 시장을 구성하는 몇 가지 서비스 범주이며, 2022년까지 가장 높은 성장률을 보이는 범주는 숙련된 간호 서비스입니다. 이는 도시화와 인구 증가로 인한 것입니다.

세계 홈헬스케어 시장은 북미, 유럽, 아시아태평양 및 기타 지역으로 분류됩니다. 예측 기간 중 아시아태평양이 가장 높은 CAGR을 기록할 것으로 예상됩니다. 그 요인으로는 의료 비용 증가, 재택치료를 지원하려는 정부의 구상 등이 있습니다.

세계의 홈헬스케어 시장에 대해 조사했으며, 제품별, 서비스별, 적응증별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 가격 분석
• 특허 분석
• 밸류체인 분석
• 공급망 분석
• 생태계/시장 맵
• Porter's Five Forces 분석
• PESTLE 분석
• 규제 상황
• 무역 분석
• 기술 분석
• 2023-2024년의 주요 컨퍼런스와 이벤트
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 주요 이해관계자와 구입 기준
• 사례 연구 분석

제6장 홈헬스케어 시장, 제품별

• 서론
• 치료용 제품
• 제품 테스트, 스크리닝 및 모니터링
• 모빌리티 케어 제품

제7장 홈헬스케어 시장, 서비스별

• 서론
• 숙련 케어 서비스
• 재활 요법 서비스
• 호스피스 및 완화 치료 서비스
• 숙련도 낮은 케어 서비스
• 호흡 요법 서비스
• 주입 요법 서비스
• 임신 케어 서비스

제8장 홈헬스케어 시장, 적응증별

• 서론
• 암
• 호흡기질환
• 운동장애
• 임신
• 심혈관질환과 고혈압
• 창상관리
• 당뇨병
• 청각 장애
• 기타

제9장 홈헬스케어 시장, 지역별

• 서론
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제10장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/비책
• 매출 점유율 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 스타트업/중소기업 평가 매트릭스
• 경쟁 시나리오

제11장 기업 개요

• 주요 참여 기업
  • FRESENIUS SE & CO. KGAA
  • ABBOTT
  • LINDE PLC
  • F. HOFFMANN-LA ROCHE
  • RESMED
  • KONINKLIJKE PHILIPS
  • GE HEALTHCARE
  • A&D COMPANY
  • INVACARE CORPORATION
  • AMEDISYS
  • LHC GROUP
  • OMRON CORPORATION
• 기타 기업
  • BAYADA HOME HEALTH CARE
  • DRIVE DEVILBISS HEALTHCARE LIMITED
  • SUNRISE MEDICAL
  • ROMA MEDICAL
  • CAREMAX REHABILITATION EQUIPMENT
  • VITALOGRAPH
  • ADVITA PFLEGEDIENST
  • RENAFAN GMBH
  • CONTEC MEDICAL SYSTEMS
  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL
  • MEDLINE INDUSTRIES
  • ADVIN HEALTH CARE

제12장 부록

영문목차

The global home healthcare market is projected to reach USD 383.0 Billion by 2028 from USD 250.0 Billion in 2023, at a CAGR of 8.9% during the forecast period. The primary driver of growth in this market is the introduction of new technologies in home healthcare goods and services.

"The therapeutic products segment accounted for the highest growth rate in the home healthcare market, by product, during the forecast period."

Products for testing, screening, and monitoring; products for therapy; and items for mobility care comprise the segments of the home healthcare market. The home healthcare market's highest growth rate in 2022 was recorded by the therapeutic goods category. The increasing incidence of chronic illnesses is primarily responsible for market expansion.

"Infusion therapy services segment accounted for the highest CAGR."

Skilled nursing, rehabilitation treatment, hospice & palliative care, unskilled care, respiratory therapy, infusion therapy, and prenatal care services are the several service categories that make up the home healthcare market. By 2022, the category with the highest growth rate was skilled nursing services. This is explained by both urbanization and population growth.

"Asia Pacific: The fastest-growing region home healthcare market."

The global home healthcare market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. Over the course of the projection period, the Asia Pacific area is expected to record the greatest CAGR. factors including increased healthcare expenses and government attempts to support at-home care.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level (27%), Director-level (18%), and Others (55%)
• By Region: North America (51%), Europe (21%), Asia- Pacific (18%), Latin America (6%), and Middle East & Africa(4%)

The key players operating in this market include Fresenius SE & Co. KGaA (Germany), Abbott (US), GE

HealthCare (US), Koninklijke Phillips NV. (Netherlands), ResMed, Inc. (US), Linde plc (Ireland), F. Hoffman-La Roche, Ltd. (Switzerland), A&D Company Limited (Japan), Bayade Home Health Care (US), Invacare Corporation (US), Amedisys (US), LHC Group, Inc. (US), OMRON Corporation (Japan), Drive DeVilbiss Healthcare (UK), Sunrise Medical (Germany), Roma Medical (UK), CAREMAX Rehabilitation Equipment Co., Ltd. (China), Vitalograph (UK), Advita Rflegedienst GmbH (Germany), RENAFAN GmbH (Germany), CONTEC MEDICAL SYSTEMS Co., Ltd. (China), B. Braun Melsungen Ag (Germany), Baxter International, Inc. (US), Medline Industries, Inc. (US), and Advin Health Care (India).

Research Coverage

This research report categorizes the home healthcare market by products, service, indicators, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the home healthcare market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the Surface disinfectant market. Competitive analysis of upcoming startups in the home healthcare market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall home healthcare market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (High prevalence of chronic diseases, growing geriatric population), restraints (Alternative Technologies), opportunities (Rising healthcare expenditure, Increasing Demand from Emerging Economies), and challenges (stringent regulations, limited insurance coverage) influencing the growth of the home healthcare market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the home healthcare market
• Market Development: Comprehensive information about lucrative markets - the report analyses the home healthcare market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the home healthcare market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Phillips NV. (Netherlands), ResMed, Inc. (US), among others in home healthcare market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • TABLE 1 INCLUSIONS AND EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
  • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH APPROACH
  • FIGURE 1 HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
  • TABLE 2 KEY DATA FROM PRIMARY SOURCES
    • 2.2.2.1 Key industry insights
    • 2.2.2.2 Breakdown of primary interviews
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HOME HEALTHCARE MARKET)
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
    • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.3.1.3 Growth forecast
    • 2.3.1.4 CAGR projections
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3.2 TOP-DOWN APPROACH
  • FIGURE 6 HOME HEALTHCARE MARKET: TOP-DOWN APPROACH
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
• 2.5 MARKET SHARE ANALYSIS
• 2.6 ASSUMPTIONS
• 2.7 GROWTH RATE ASSUMPTIONS
• 2.8 LIMITATIONS
• 2.9 RISK ASSESSMENT
• 2.10 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD BILLION)
• FIGURE 9 HOME HEALTHCARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
• FIGURE 10 HOME HEALTHCARE MARKET, BY SERVICE, 2023 VS. 2028 (USD BILLION)
• FIGURE 11 HOME HEALTHCARE MARKET, BY INDICATION, 2023 VS. 2028 (USD BILLION)
• FIGURE 12 HOME HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 HOME HEALTHCARE MARKET OVERVIEW
  • FIGURE 13 RISING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH
• 4.2 GEOGRAPHIC GROWTH OPPORTUNITIES IN HOME HEALTHCARE MARKET
  • FIGURE 14 JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• 4.3 HOME HEALTHCARE MARKET: GEOGRAPHIC MIX
  • FIGURE 15 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
• 4.4 HOME HEALTHCARE MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
  • FIGURE 16 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 17 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rapid growth in elderly population and rising incidence of chronic diseases
  • TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION)
    • 5.2.1.2 Rising R&D investments
  • TABLE 4 PRODUCT LAUNCHES
    • 5.2.1.3 Need for cost-effective healthcare delivery due to rising costs
    • 5.2.1.4 Increased preference for personalized care
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Changing reimbursement policies
    • 5.2.2.2 Limited insurance coverage
    • 5.2.2.3 Patient safety concerns
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising focus on telehealth
    • 5.2.3.2 Untapped developing regions
    • 5.2.3.3 Growing demand for home-use therapeutic devices
    • 5.2.3.4 Growing demand for home sleep apnea tests
    • 5.2.3.5 Rising preference for home hemodialysis treatment
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of home care workers
    • 5.2.4.2 Lack of supporting infrastructure
• 5.3 PRICING ANALYSIS
  • 5.3.1 PRICING MODEL ANALYSIS
  • TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2023)
  • TABLE 6 AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS, BY REGION (2023)
• 5.4 PATENT ANALYSIS
  • FIGURE 18 PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2013-DECEMBER 2022)
  • 5.4.1 LIST OF KEY PATENTS
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
• 5.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 20 HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM/MARKET MAP
  • FIGURE 21 HOME HEALTHCARE MARKET: ECOSYSTEM/MARKET MAP
  • 5.7.1 HOME HEALTHCARE MARKET: ROLE IN ECOSYSTEM
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 PULSE OXIMETERS
  • TABLE 7 PULSE OXIMETERS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1.1 Threat of new entrants
    • 5.8.1.2 Threat of substitutes
    • 5.8.1.3 Bargaining power of suppliers
    • 5.8.1.4 Bargaining power of buyers
    • 5.8.1.5 Degree of competition
  • 5.8.2 HEARING AIDS
  • TABLE 8 HEARING AIDS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.2.1 Threat of new entrants
    • 5.8.2.2 Threat of substitutes
    • 5.8.2.3 Bargaining power of buyers
    • 5.8.2.4 Bargaining power of suppliers
    • 5.8.2.5 Degree of competition
• 5.9 PESTLE ANALYSIS
• 5.10 REGULATORY LANDSCAPE
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10.1 NORTH AMERICA
    • 5.10.1.1 US
  • TABLE 14 US FDA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
    • 5.10.1.2 Canada
  • TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • FIGURE 23 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA
  • 5.10.2 EUROPE
  • FIGURE 24 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES
  • 5.10.3 ASIA PACIFIC
    • 5.10.3.1 Japan
  • TABLE 17 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
    • 5.10.3.2 China
  • TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    • 5.10.3.3 India
• 5.11 TRADE ANALYSIS
  • 5.11.1 TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS
  • TABLE 19 IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017-2021 (USD MILLION)
  • TABLE 20 EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017-2021 (USD MILLION)
• 5.12 TECHNOLOGY ANALYSIS
• 5.13 KEY CONFERENCES & EVENTS IN 2023-2024
  • TABLE 21 HOME HEALTHCARE MARKET: KEY CONFERENCES & EVENTS, 2023-2024
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 25 REVENUE SHIFT IN HOME HEALTHCARE
• 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
  • 5.15.2 BUYING CRITERIA
  • FIGURE 27 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
  • TABLE 23 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 CASE STUDY: FUTURE OF HOME HEALTH PROJECT

6 HOME HEALTHCARE MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 24 HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 6.2 THERAPEUTIC PRODUCTS
  • TABLE 25 KEY THERAPEUTIC PRODUCTS OFFERED
  • TABLE 26 THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 27 THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.1 DIALYSIS EQUIPMENT
    • 6.2.1.1 Dialysis equipment to hold largest market share
  • TABLE 28 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.2 WOUND CARE PRODUCTS
    • 6.2.2.1 Decreased costs and higher convenience and comfort to drive market
  • TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.3 IV EQUIPMENT
    • 6.2.3.1 Accuracy and growing target disease prevalence to ensure market growth
  • TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.4 SLEEP APNEA THERAPEUTIC DEVICES
    • 6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market
  • TABLE 31 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.5 INSULIN DELIVERY DEVICES
    • 6.2.5.1 High incidence of diabetes to drive market
  • TABLE 32 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.6 OXYGEN DELIVERY SYSTEMS
    • 6.2.6.1 Technological advancements in oxygen therapy products to drive market
  • TABLE 33 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.7 INHALERS
    • 6.2.7.1 High incidence of asthma to boost market
  • TABLE 34 INHALERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.8 NEBULIZERS
    • 6.2.8.1 Effectiveness over oral dosages to push preference for nebulizers
  • TABLE 35 NEBULIZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.9 VENTILATORS
    • 6.2.9.1 Convenience and comfort to sustain end-user preference
  • TABLE 36 VENTILATORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.10 OTHER THERAPEUTIC PRODUCTS
  • TABLE 37 OTHER THERAPEUTIC PRODUCTS, BY REGION, 2021-2028 (USD MILLION)
• 6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
  • TABLE 38 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED
  • TABLE 39 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 40 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.1 BLOOD GLUCOSE MONITORS
    • 6.3.1.1 Increasing prevalence of diabetes to drive market growth
  • TABLE 41 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.2 HEARING AIDS
    • 6.3.2.1 High incidence of hearing impairment to drive market
  • TABLE 42 HEARING AIDS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.3 ACTIVITY MONITORS & WRISTBANDS
    • 6.3.3.1 Increasing prevalence of chronic diseases to bolster demand for activity monitors
  • TABLE 43 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.4 ECG/EKG DEVICES
    • 6.3.4.1 High prevalence of CVD to support demand
  • TABLE 44 ECG/EKG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.5 TEMPERATURE MONITORING DEVICES
    • 6.3.5.1 Technological innovations and increasing awareness to drive growth
  • TABLE 45 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.6 HEART RATE MONITORS
    • 6.3.6.1 Continuous cardiac parameter monitoring capabilities to drive demand
  • TABLE 46 HEART RATE MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.7 PULSE OXIMETERS
    • 6.3.7.1 Rising disease incidence and wide usage of pulse oximetry to ensure strong demand
  • TABLE 47 PULSE OXIMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.8 OVULATION & PREGNANCY TEST KITS
    • 6.3.8.1 Privacy, convenience, accessibility, and quick results to drive market
  • TABLE 48 OVULATION & PREGNANCY TEST KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.9 BLOOD PRESSURE MONITORS
    • 6.3.9.1 Rising patient population for hypertension and CVD to drive market
  • TABLE 49 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.10 HIV TEST KITS
    • 6.3.10.1 Rising prevalence of HIV to drive market
  • TABLE 50 HIV TEST KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.11 FETAL MONITORING DEVICES
    • 6.3.11.1 Remote-based care by portable fetal monitoring systems to drive market growth
  • TABLE 51 FETAL MONITORING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.12 HOLTER & EVENT MONITORS
    • 6.3.12.1 Rising awareness of preventive care and technological advancements to drive market
  • TABLE 52 HOLTER & EVENT MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.13 DRUG & ALCOHOL TEST KITS
    • 6.3.13.1 Rising consumption of drugs among teens to support market growth
  • TABLE 53 DRUG & ALCOHOL TEST KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.14 COAGULATION MONITORING PRODUCTS
    • 6.3.14.1 Rising use of anticoagulant therapy and availability of home-use kits to drive market
  • TABLE 54 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.15 PEAK FLOW METERS
    • 6.3.15.1 High portability and cost-efficiency to ensure adoption
  • TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.16 COLON CANCER TEST KITS
    • 6.3.16.1 High incidence of colorectal cancer to drive market growth
  • TABLE 56 COLON CANCER TEST KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.17 EEG DEVICES
    • 6.3.17.1 Wide patient population for epilepsy to drive market for EEG devices
  • TABLE 57 EEG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.18 HOME SLEEP TESTING DEVICES
    • 6.3.18.1 Cost-effectiveness of home-based sleep tests to fuel growth
  • TABLE 58 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.19 CHOLESTEROL TESTING PRODUCTS
    • 6.3.19.1 Rising obesity levels and CVD incidence to support market
  • TABLE 59 CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.20 HOME HBA1C TEST KITS
    • 6.3.20.1 High incidence of diabetes to drive market
  • TABLE 60 HOME HBA1C TEST KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.4 MOBILITY CARE PRODUCTS
  • TABLE 61 KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 62 MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 63 MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4.1 WHEELCHAIRS
    • 6.4.1.1 Increased preference for wheelchairs to boost demand
  • TABLE 64 WHEELCHAIRS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4.2 MOBILITY SCOOTERS
    • 6.4.2.1 High cost to affect end-user adoption
  • TABLE 65 MOBILITY SCOOTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4.3 WALKERS & ROLLATORS
    • 6.4.3.1 Difficulties in using walkers and availability of alternatives to restrain market
  • TABLE 66 WALKERS & ROLLATORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4.4 CRUTCHES
    • 6.4.4.1 High preference for axilla crutches to support demand
  • TABLE 67 CRUTCHES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4.5 CANES
    • 6.4.5.1 Wide usage of canes to drive market
  • TABLE 68 CANES MARKET, BY REGION, 2021-2028 (USD MILLION)

7 HOME HEALTHCARE MARKET, BY SERVICE

• 7.1 INTRODUCTION
  • TABLE 69 US: AVERAGE SENIOR CARE COST, BY TYPE, 2022
  • TABLE 70 HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 71 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.2 SKILLED NURSING SERVICES
  • 7.2.1 SKILLED NURSING SERVICES TO DOMINATE MARKET
  • TABLE 72 SKILLED NURSING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.3 REHABILITATION THERAPY SERVICES
  • 7.3.1 RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND
  • TABLE 73 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.4 HOSPICE & PALLIATIVE CARE SERVICES
  • 7.4.1 RISING GERIATRIC POPULATION TO DRIVE DEMAND
  • TABLE 74 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.5 UNSKILLED CARE SERVICES
  • 7.5.1 COST-EFFECTIVENESS TO DRIVE GROWTH
  • TABLE 75 UNSKILLED SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.6 RESPIRATORY THERAPY SERVICES
  • 7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET
  • TABLE 76 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.7 INFUSION THERAPY SERVICES
  • 7.7.1 SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND
  • TABLE 77 INFUSION THERAPY SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.8 PREGNANCY CARE SERVICES
  • 7.8.1 NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH
  • TABLE 78 PREGNANCY CARE SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

8 HOME HEALTHCARE MARKET, BY INDICATION

• 8.1 INTRODUCTION
  • TABLE 79 HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 80 HOME HEALTHCARE INDICATIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.2 CANCER
  • 8.2.1 CANCER TO DOMINATE INDICATIONS MARKET
  • TABLE 81 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
  • TABLE 82 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2021-2028 (USD MILLION)
• 8.3 RESPIRATORY DISEASES
  • 8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET
  • TABLE 83 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021-2028 (USD MILLION)
• 8.4 MOVEMENT DISORDERS
  • 8.4.1 GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT
  • TABLE 84 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021-2028 (USD MILLION)
• 8.5 PREGNANCY
  • 8.5.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH
  • TABLE 85 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2021-2028 (USD MILLION)
• 8.6 CVD & HYPERTENSION
  • 8.6.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH
  • TABLE 86 HOME HEALTHCARE MARKET FOR CVD & HYPERTENSION, BY REGION, 2021-2028 (USD MILLION)
• 8.7 WOUND CARE
  • 8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET
  • TABLE 87 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2021-2028 (USD MILLION)
• 8.8 DIABETES
  • 8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH
  • TABLE 88 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2021-2028 (USD MILLION)
• 8.9 HEARING DISORDERS
  • 8.9.1 WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH
  • TABLE 89 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2021-2028 (USD MILLION)
• 8.10 OTHER INDICATIONS
  • TABLE 90 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2021-2028 (USD MILLION)

9 HOME HEALTHCARE MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 91 HOME HEALTHCARE MARKET, BY REGION, 2021-2028 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 28 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
  • TABLE 92 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 93 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 94 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 95 NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 96 NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 97 NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 98 NORTH AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American home healthcare market
  • TABLE 100 US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 101 US: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 102 US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 103 US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 104 US: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 105 US: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 106 US: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Rising geriatric population to drive market
  • TABLE 107 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 108 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 109 CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 110 CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 111 CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 112 CANADA: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 113 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
• 9.3 EUROPE
  • 9.3.1 EUROPE: RECESSION IMPACT
  • TABLE 114 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 115 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 116 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 117 EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 118 EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 119 EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 120 EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 121 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to retain market leadership in Europe
  • TABLE 122 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 123 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 124 GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 125 GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 126 GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 127 GERMANY: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 128 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.3.3 UK
    • 9.3.3.1 Rising burden of chronic diseases to boost market growth
  • TABLE 129 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 130 UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 131 UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 132 UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 133 UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 134 UK: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 135 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.3.4 FRANCE
    • 9.3.4.1 Government support and initiatives taken by market players to boost market
  • TABLE 136 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 137 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 138 FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 139 FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 140 FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 141 FRANCE: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 142 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.3.5 ITALY
    • 9.3.5.1 Rising geriatric population and favorable government policy to drive market
  • TABLE 143 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 144 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 145 ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 146 ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 147 ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 148 ITALY: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 149 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.3.6 SPAIN
    • 9.3.6.1 Rising geriatric population and incidence of chronic conditions to drive market growth
  • TABLE 150 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 151 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 152 SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 153 SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 154 SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 155 SPAIN: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 156 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.3.7 REST OF EUROPE
  • TABLE 157 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 158 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 159 REST OF EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 160 REST OF EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 161 REST OF EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 162 REST OF EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 163 REST OF EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 29 APAC: HOME HEALTHCARE MARKET SNAPSHOT
  • TABLE 164 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.4.2 JAPAN
    • 9.4.2.1 Japan to command largest share of APAC market
  • TABLE 172 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 173 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 174 JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 175 JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 176 JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 177 JAPAN: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 178 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.4.3 CHINA
    • 9.4.3.1 Healthcare development and reforms to drive market growth
  • TABLE 179 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 180 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 181 CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 182 CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 183 CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 184 CHINA: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 185 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing target patient population to drive market
  • TABLE 186 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 187 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 188 INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 189 INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 190 INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 191 INDIA: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 192 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.4.5 REST OF ASIA PACIFIC
  • TABLE 193 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
• 9.5 REST OF THE WORLD
  • 9.5.1 REST OF THE WORLD: RECESSION IMPACT
  • TABLE 200 ROW: HOME HEALTHCARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 201 ROW: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 202 ROW: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 203 ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 204 ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 205 ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 206 ROW: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 207 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.5.2 LATIN AMERICA
    • 9.5.2.1 Aging population to favor market growth
  • TABLE 208 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 209 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 210 LATIN AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 211 LATIN AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 212 LATIN AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 213 LATIN AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 214 LATIN AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 9.5.3 MIDDLE EAST & AFRICA
  • TABLE 215 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • 9.5.3.1 GCC Countries
      • 9.5.3.1.1 Rising focus on expanding and improving health infrastructure to drive market
  • TABLE 223 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • 9.5.3.2 Rest of the Middle East & Africa
  • TABLE 230 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 231 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 232 ROMEA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 233 ROMEA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 234 ROMEA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 235 ROMEA: HOME HEALTHCARE MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • TABLE 236 ROMEA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
  • TABLE 237 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HOME HEALTHCARE PRODUCT MANUFACTURERS
• 10.3 REVENUE SHARE ANALYSIS
  • FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS
• 10.4 MARKET SHARE ANALYSIS
  • FIGURE 31 HOME HEALTHCARE MARKET SHARE ANALYSIS (2022)
  • TABLE 238 HOME HEALTHCARE MARKET: DEGREE OF COMPETITION
• 10.5 COMPANY EVALUATION MATRIX
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • FIGURE 32 HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX, 2022
  • 10.5.5 COMPANY FOOTPRINT
  • TABLE 239 PRODUCT FOOTPRINT (FIVE PLAYERS)
  • TABLE 240 REGIONAL FOOTPRINT (FIVE PLAYERS)
  • TABLE 241 COMPETITIVE BENCHMARKING OF KEY PLAYERS
  • FIGURE 33 COMPANY FOOTPRINT (FIVE COMPANIES)
• 10.6 START-UP/SME EVALUATION MATRIX
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • FIGURE 34 HOME HEALTHCARE MARKET: START-UP/SME EVALUATION MATRIX, 2022
  • 10.6.5 COMPETITIVE BENCHMARKING
  • TABLE 242 HOME HEALTHCARE MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 243 COMPETITIVE BENCHMARKING OF START-UPS/SMES
• 10.7 COMPETITIVE SCENARIO
  • 10.7.1 PRODUCT LAUNCHES & APPROVALS
  • TABLE 244 HOME HEALTHCARE MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
  • 10.7.2 DEALS
  • TABLE 245 HOME HEALTHCARE MARKET: DEALS (JANUARY 2020-DECEMBER 2023)
  • 10.7.3 OTHER DEVELOPMENTS
  • TABLE 246 HOME HEALTHCARE MARKET: OTHER DEVELOPMENTS (JANUARY 2020-DECEMBER 2023)

11 COMPANY PROFILES

• (Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 11.1 KEY PLAYERS
  • 11.1.1 FRESENIUS SE & CO. KGAA
  • TABLE 247 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW
  • FIGURE 35 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2022)
  • TABLE 248 FRESENIUS SE & CO. KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 249 FRESENIUS SE & CO. KGAA: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 250 FRESENIUS SE & CO. KGAA: DEALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 251 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS (JANUARY 2020-DECEMBER 2023)
  • 11.1.2 ABBOTT
  • TABLE 252 ABBOTT: COMPANY OVERVIEW
  • FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2022)
  • TABLE 253 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 254 ABBOTT: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 255 ABBOTT: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.1.3 LINDE PLC
  • TABLE 256 LINDE: COMPANY OVERVIEW
  • FIGURE 37 LINDE: COMPANY SNAPSHOT (2022)
  • TABLE 257 LINDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 11.1.4 F. HOFFMANN-LA ROCHE
  • TABLE 258 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
  • FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
  • TABLE 259 F. HOFFMAN-LA ROCHE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 260 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • TABLE 261 F. HOFFMANN-LA ROCHE: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.1.5 RESMED
  • TABLE 262 RESMED: COMPANY OVERVIEW
  • FIGURE 39 RESMED: COMPANY SNAPSHOT (2022)
  • TABLE 263 RESMED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 264 RESMED: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • TABLE 265 RESMED: DEALS
  • 11.1.6 KONINKLIJKE PHILIPS
  • TABLE 266 KONINKLIJKE PHILIPS: COMPANY OVERVIEW
  • FIGURE 40 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2022)
  • TABLE 267 KONINKLIJKE PHILIPS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 268 KONINKLIJKE PHILIPS: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • TABLE 269 KONINKLIJKE PHILIPS: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.1.7 GE HEALTHCARE
  • TABLE 270 GE HEALTHCARE: COMPANY OVERVIEW
  • FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
  • TABLE 271 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 272 GE HEALTHCARE: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.1.8 A&D COMPANY
  • TABLE 273 A&D COMPANY: COMPANY OVERVIEW
  • FIGURE 42 A&D COMPANY: COMPANY SNAPSHOT (2022)
  • TABLE 274 A&D COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 275 A&D COMPANY: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • 11.1.9 INVACARE CORPORATION
  • TABLE 276 INVACARE CORPORATION: COMPANY OVERVIEW
  • FIGURE 43 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 277 INVACARE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 278 INVACARE CORPORATION: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • 11.1.10 AMEDISYS
  • TABLE 279 AMEDISYS: COMPANY OVERVIEW
  • FIGURE 44 AMEDISYS: COMPANY SNAPSHOT (2022)
  • TABLE 280 AMEDISYS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 281 AMEDISYS: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.1.11 LHC GROUP
  • TABLE 282 LHC GROUP: COMPANY OVERVIEW
  • FIGURE 45 LHC GROUP: COMPANY SNAPSHOT (2022)
  • TABLE 283 LHC GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 284 LHC GROUP: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.1.12 OMRON CORPORATION
  • TABLE 285 OMRON CORPORATION: COMPANY OVERVIEW
  • FIGURE 46 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 286 OMRON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 287 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 288 OMRON CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
• 11.2 OTHER PLAYERS
  • 11.2.1 BAYADA HOME HEALTH CARE
  • 11.2.2 DRIVE DEVILBISS HEALTHCARE LIMITED
  • 11.2.3 SUNRISE MEDICAL
  • 11.2.4 ROMA MEDICAL
  • 11.2.5 CAREMAX REHABILITATION EQUIPMENT
  • 11.2.6 VITALOGRAPH
  • 11.2.7 ADVITA PFLEGEDIENST
  • 11.2.8 RENAFAN GMBH
  • 11.2.9 CONTEC MEDICAL SYSTEMS
  • 11.2.10 B. BRAUN MELSUNGEN AG
  • 11.2.11 BAXTER INTERNATIONAL
  • 11.2.12 MEDLINE INDUSTRIES
  • 11.2.13 ADVIN HEALTH CARE
• *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS